PATH: Influenza, Human trials
The registry lists 11 Influenza, Human studies with PATH as lead sponsor. 0 are open to participants now and 9 have results posted.
Phase 1 5Phase 2 3Phase 3 2Phase 4 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu VaccineCompletedNCT03300050Phase 1Results posted
- Immunogenicity of H5N1 Vaccine Following H5N2CompletedNCT02153671Phase 2Results posted
- Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/CALIFORNIA/66/395 (H2N2) Influenza VaccineCompletedNCT01982331Phase 1Results posted
- Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in SenegalCompletedNCT01854632Phase 3Results posted
- A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in BangladeshCompletedNCT01797029Phase 3Results posted
- Reactogenicity, Safety, and Immunogenicity of a Live Monovalent H5N2 Influenza VaccineCompletedNCT01719783Phase 1Results posted
- Safety Trial of Live Attenuated Influenza (H7N3) VaccineCompletedNCT01511419Phase 1Results posted
- Safety Trial of Monovalent Whole Virus Influenza (H1N1) VaccineCompletedNCT01507779Phase 1Results posted
- Intradermal Influenza Vaccine Study in EldersCompletedNCT00504231Phase 2Results posted
- Immunogenicity and Safety Trial of Adjuvanted and Non-adjuvanted Trivalent Influenza Vaccine in Tropical AfricaCompletedNCT01819155Phase 2
- Inactivated Influenza Vaccine Effectiveness in Tropical AfricaCompletedNCT00893906Phase 4